Recent News
View All
Thursday, August 19, 2010
EntreMed Receives NASDAQ Listing Rule 5550(b)(2) Determination Letter
Monday, August 16, 2010
EntreMed Reports Second Quarter 2010 Financial Results
Tuesday, July 20, 2010
EntreMed Regains Compliance With NASDAQ Minimum Bid Price Rule
Tuesday, July 13, 2010
EntreMed’s ENMD-2076 Demonstrates Significant Anti-Cancer Activity in Multiple Myeloma Preclinical Models
Wednesday, June 30, 2010
EntreMed Announces Reverse Stock Split
Stay Informed
Enter your e-mail address to receive press releases electronically. (Manage your subscription)